EUVIMEDEUVIMED entdecken
Crossref

Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection

Hiroshi Ichise iD, Emily Speranza iD, Federica La Russa iD, Tibor Z Veres iD, Colin J Chu iD, Anita Gola, Beatrice H Clark iD, Ronald N Germain iD

Science · 20.11.2025 · 390 (6775)

DOI: 10.1126/science.adr4635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 20.11.2025. Verfasst von Hiroshi Ichise und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health…. Hauptthemen laut MEDLINE: Lung, Neutrophils, Orthomyxoviridae Infections, Pneumonia, Viral. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maintaining tissue function while eliminating infected cells is fundamental, and inflammatory damage plays a major contribution to lethality after lung infection. We tested 50 immunomodulatory regimes to determine their ability to protect mice from lethal infection. Only neutrophil depletion soon after infection prevented death from influenza. This result suggests that the infected host passed an early tipping point after which limiting innate damage alone could not rescue lung function. We investigated treatments that could have efficacy when administered later in infection. We found that partial limitation of viral spread together with enhancement of epithelial repair, by interferon blockade or limiting CD8 + T cell–mediated killing of epithelial cells, reduced lethality. This finding highlights the importance of rebalancing repair and damage processes in the survival of pulmonary infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LungNeutrophilsOrthomyxoviridae InfectionsPneumonia, ViralAdaptive ImmunityImmunomodulationAnimalsFemaleMiceCD8-Positive T-LymphocytesEpithelial CellsImmunity, InnateInterferonsLymphocyte DepletionMice, Inbred C57BLOseltamivirAntiviral AgentsEnzyme InhibitorsImmunomodulating Agents

Substanzen

InterferonsOseltamivirAntiviral AgentsEnzyme InhibitorsImmunomodulating Agents

Autor:innen und Institutionen

  • Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Florida Research and Innovation Center, Cleveland Clinic Lerner Research Institute, Port Saint Lucie, FL, USA.
  • UCL Institute of Ophthalmology, University College London, London, UK.
  • Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

ORCID-Profile: Hiroshi Ichise, Emily Speranza, Federica La Russa, Tibor Z Veres, Colin J Chu, Beatrice H Clark, Ronald N Germain

Zitieren

APA

Ichise, H., Speranza, E., La Russa, F., Veres, T. Z., Chu, C. J., Gola, A., Clark, B. H., & Germain, R. N. (2025). Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection. Science, 390(6775). https://doi.org/10.1126/science.adr4635

Vancouver

Ichise H, Speranza E, La Russa F, Veres TZ, Chu CJ, Gola A, et al. Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection. Science. 2025;390(6775). doi:10.1126/science.adr4635

BibTeX
@article{Ichise2025,
  author = {Ichise, Hiroshi and Speranza, Emily and La Russa, Federica and Veres, Tibor Z and Chu, Colin J and Gola, Anita and Clark, Beatrice H and Germain, Ronald N},
  title = {Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection},
  journal = {Science},
  year = {2025},
  volume = {390},
  number = {6775},
  doi = {10.1126/science.adr4635}
}
Kostenlos starten →